Replies to post #12438 on Sorrento Therapeutics Inc (SRNE)

[dia76ca]

Sorrento's cancer portfolio is outstanding.
1. ABIVERTINIB(3rd gen.BTK) multi-billion potential in a dozen cancers
2. ADNAB(Mayo Clinic) in a dozen cancers
3. CAR-T's and ADC's in a dozen cancers
4. DAR-T in a dozen cancers
5. second generation Oncolytic virus in a dozen cancers